Autobahn Therapeutics website screenshot

Autobahn Therapeutics

Autobahn Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California, developing regenerative medicines for central nervous system (CNS) disorders. The company pairs a proprietary brain-targeting chemistry platform - which creates orally administered small-molecule prodrugs designed to cross the blood-brain barrier - with validated human biology and biomarker-driven development strategies. Its pipeline includes elunetirom (its lead clinical program, being developed for indications such as bipolar depression), ABX-101 (a next-generation CNS-active S1P molecule), and ABX-003. Autobahn is backed by venture investors including Canaan Partners and Insight Partners. This profile is maintained in the API Evangelist network; the company does not currently publish a public developer API, so this record captures company identity and published web properties only.

Autobahn Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Biotechnology, Central Nervous System, and Neuroscience.

Autobahn Therapeutics’ developer surface includes engineering blog, support, and 8 more developer resources.

7.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0
0 APIs
CompanyBiopharmaceuticalBiotechnologyCentral Nervous SystemNeuroscienceDrug DevelopmentRegenerative MedicineSmall MoleculeClinical StageHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/autobahn-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Autobahn Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 2

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: autobahn-therapeutics
name: Autobahn Therapeutics
description: Autobahn Therapeutics is a clinical-stage biopharmaceutical company based in San Diego, California, developing
  regenerative medicines for central nervous system (CNS) disorders. The company pairs a proprietary brain-targeting chemistry
  platform - which creates orally administered small-molecule prodrugs designed to cross the blood-brain barrier - with validated
  human biology and biomarker-driven development strategies. Its pipeline includes elunetirom (its lead clinical program,
  being developed for indications such as bipolar depression), ABX-101 (a next-generation CNS-active S1P molecule), and ABX-003.
  Autobahn is backed by venture investors including Canaan Partners and Insight Partners. This profile is maintained in the
  API Evangelist network; the company does not currently publish a public developer API, so this record captures company identity
  and published web properties only.
url: https://raw.githubusercontent.com/api-evangelist/autobahn-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biopharmaceutical
- Biotechnology
- Central Nervous System
- Neuroscience
- Drug Development
- Regenerative Medicine
- Small Molecule
- Clinical Stage
- Healthcare
image: https://www.autobahntx.com/wp-content/themes/autobahn/assets/images/logo.svg
apis: []
common:
- type: DomainSecurity
  url: security/autobahn-therapeutics-domain-security.yml
- type: Website
  url: https://www.autobahntx.com
  name: Autobahn Therapeutics
- type: About
  url: https://autobahntx.com/about-us/
  name: About Us
- type: Pipeline
  url: https://autobahntx.com/our-pipeline/
  name: Our Pipeline
- type: Science
  url: https://autobahntx.com/our-science/
  name: Our Science
- type: Blog
  url: https://autobahntx.com/news/
  name: News
- type: Careers
  url: https://autobahntx.com/careers/
  name: Careers
- type: Support
  url: https://autobahntx.com/contact-us/
  name: Contact Us
- type: PrivacyPolicy
  url: https://autobahntx.com/privacy-policy/
  name: Privacy Policy
- type: LinkedIn
  url: https://www.linkedin.com/company/autobahn-therapeutics-inc/
  name: LinkedIn
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/autobahn-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/autobahn-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/autobahn-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.